🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "specific steps to deal with household expense challenges" in next month's Budget.

Speaking to the BBC, she emphasized that reducing inflation is a collective duty of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven developed nations this calendar year and next.

Potential Energy Cost Interventions

Reports indicate the government could take action to lower energy bills, such as by cutting the current 5% rate of VAT charged on energy.

An additional possibility is to lower some of the policy costs currently included in bills.

Budgetary Constraints and Expert Predictions

The administration will obtain the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much scope there is for such actions.

The expectation from the majority of analysts is that the Chancellor will have to announce tax increases or spending cuts in order to adhere to her declared fiscal targets.

Previously on Thursday, estimates showed there was a £22bn shortfall for the chancellor to fill, which is at the lower end of projections.

"It is a collective job between the central bank and the government to further reduce some of the sources of price increases," Reeves stated to the BBC in the US capital, at the conferences of the IMF and World Bank.

Revenue Commitments and Global Issues

While much of the focus has been on likely tax increases, the chancellor said the latest figures from the fiscal watchdog had not altered her pledge to campaign commitments not to increase rates on income tax, VAT or social security contributions.

She blamed an "uncertain world" with increasing international and commercial concerns for the fiscal tax moves, likely to be targeted on those "with the broadest shoulders."

International Economic Disputes

Commenting on worries about the UK's economic relations with the Asian nation she said: "The UK's security interests invariably are paramount."

Recent statement by China to strengthen export controls on critical minerals and other materials that are key for advanced tech manufacturing led US President Donald Trump to suggest an further 100% import tax on goods from China, raising the prospect of an all-out commercial conflict between the two global powers.

The US Treasury Secretary described the Chinese decision "economic coercion" and "a international production power grab."

Inquired about accepting the US offer to participate in its conflict with China, the Chancellor said she was "extremely troubled" by Chinese actions and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "damaging for the international commerce and causes additional obstacles."

"I believe there are areas where we must challenge China, but there are also important opportunities to export to China's economy, including banking sector and other sectors of the economy. We've got to get that balance correct."

The chancellor also confirmed she was collaborating with other major economies "regarding our own essential resources approach, so that we are less reliant."

NHS Medicine Costs and Investment

Reeves also acknowledged that the cost the National Health Service pays for medicines could go up as a result of current discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and funding.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either pausing or abandoning operations in the United Kingdom, with several attributing the insufficient payments they are receiving.

Last month, the government science advisor said the price the health service spends on drugs would need to go up to stop companies and drug research funding departing from the UK.

Reeves informed the BBC: "We have seen as a result of the pricing regime, that clinical trials, recent pharmaceuticals have not been provided in the UK in the way that they are in other continental states."

"The objective is to guarantee that individuals receiving treatment from the National Health Service are can access the finest critical medicines in the world. And so we are reviewing these issues, and... looking to secure increased funding into the UK."